11,768 Shares in Astera Labs, Inc. $ALAB Purchased by Mirador Capital Partners LP

Mirador Capital Partners LP purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the 2nd quarter, Holdings Channel.com reports. The fund purchased 11,768 shares of the company’s stock, valued at approximately $5,684,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Royal Bank of Canada raised its stake in shares of Astera Labs by 167.3% during the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after purchasing an additional 95,409 shares during the last quarter. AQR Capital Management LLC grew its position in Astera Labs by 213.4% in the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after buying an additional 7,756 shares during the last quarter. Empowered Funds LLC grew its position in Astera Labs by 917.3% in the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after buying an additional 4,183 shares during the last quarter. First Trust Advisors LP increased its stake in Astera Labs by 102.0% in the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after buying an additional 56,952 shares during the period. Finally, Brown Advisory Inc. raised its position in Astera Labs by 54.9% during the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock worth $505,000 after buying an additional 1,977 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. Barclays raised their target price on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research note on Monday, July 20th. JPMorgan Chase & Co. boosted their price target on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Royal Bank Of Canada increased their price target on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a report on Wednesday. Stifel Nicolaus raised their price objective on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research report on Wednesday, June 24th. Finally, Susquehanna lifted their price objective on Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a report on Friday, July 31st. Thirteen equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $325.25.

Astera Labs Stock Performance

Astera Labs stock opened at $318.43 on Thursday. The company has a market cap of $54.58 billion, a P/E ratio of 157.64, a price-to-earnings-growth ratio of 4.19 and a beta of 3.84. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48. The business has a fifty day moving average of $360.98 and a two-hundred day moving average of $233.52.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 20.46%. The business’s revenue for the quarter was up 104.5% on a year-over-year basis. During the same period in the prior year, the company posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Sell-side analysts predict that Astera Labs, Inc. will post 1.86 EPS for the current year.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs reported record Q2 revenue of $392.4 million, up 27% sequentially and 104.5% year over year. Adjusted earnings of $0.80 per share exceeded the $0.69 consensus estimate, while revenue surpassed the $360.85 million estimate. Astera Labs Reports Second Quarter 2026 Financial Results
• Positive Sentiment: Management guided for Q3 revenue of $540 million to $560 million and EPS of $1.16 to $1.21, well above consensus estimates of approximately $410.3 million in revenue and $0.73 in EPS. The outlook implies roughly 40% sequential revenue growth. Astera Labs Analysts Boost Their Forecasts Following Better-Than-Expected Q2 Earnings
• Positive Sentiment: Demand for PCIe 6 connectivity products contributed more than half of Q2 sales, while the Scorpio X-Series fabric switch entered volume production one quarter ahead of schedule. The Scorpio ramp is expected to be the primary driver of Q3 growth and supports the company’s AI-infrastructure expansion story. Astera Labs Q2 Earnings Beat on PCIe 6 and Scorpio Strength
• Positive Sentiment: Needham raised its price target to $425 from $260 and maintained a Buy rating, indicating continued analyst confidence in Astera Labs’ growth prospects. Needham Raises Astera Labs Price Target

Insider Activity

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 3,505 shares of the stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total value of $1,577,250.00. Following the completion of the transaction, the director directly owned 57,466 shares of the company’s stock, valued at approximately $25,859,700. This trade represents a 5.75% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 796 shares of Astera Labs stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $291.03, for a total transaction of $231,659.88. Following the sale, the general counsel owned 103,343 shares of the company’s stock, valued at approximately $30,075,913.29. The trade was a 0.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 1,244,395 shares of company stock valued at $358,865,571 in the last quarter. Insiders own 10.40% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.